These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 27229535)
1. Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cells. Corsaro A; Bajetto A; Thellung S; Begani G; Villa V; Nizzari M; Pattarozzi A; Solari A; Gatti M; Pagano A; Würth R; Daga A; Barbieri F; Florio T Oncotarget; 2016 Jun; 7(25):38638-38657. PubMed ID: 27229535 [TBL] [Abstract][Full Text] [Related]
2. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells. Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969 [TBL] [Abstract][Full Text] [Related]
3. Prion Protein in Glioblastoma Multiforme. Ryskalin L; Busceti CL; Biagioni F; Limanaqi F; Familiari P; Frati A; Fornai F Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31618844 [TBL] [Abstract][Full Text] [Related]
4. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells. Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866 [TBL] [Abstract][Full Text] [Related]
5. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme. Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity. Gatti M; Pattarozzi A; Bajetto A; Würth R; Daga A; Fiaschi P; Zona G; Florio T; Barbieri F Toxicology; 2013 Dec; 314(2-3):209-20. PubMed ID: 24157575 [TBL] [Abstract][Full Text] [Related]
7. EZH2 is essential for glioblastoma cancer stem cell maintenance. Suvà ML; Riggi N; Janiszewska M; Radovanovic I; Provero P; Stehle JC; Baumer K; Le Bitoux MA; Marino D; Cironi L; Marquez VE; Clément V; Stamenkovic I Cancer Res; 2009 Dec; 69(24):9211-8. PubMed ID: 19934320 [TBL] [Abstract][Full Text] [Related]
8. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal. Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223 [TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice. Wang D; Fu L; Sun H; Guo L; DuBois RN Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008 [TBL] [Abstract][Full Text] [Related]
11. SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Gangemi RM; Griffero F; Marubbi D; Perera M; Capra MC; Malatesta P; Ravetti GL; Zona GL; Daga A; Corte G Stem Cells; 2009 Jan; 27(1):40-8. PubMed ID: 18948646 [TBL] [Abstract][Full Text] [Related]
12. Girdin maintains the stemness of glioblastoma stem cells. Natsume A; Kato T; Kinjo S; Enomoto A; Toda H; Shimato S; Ohka F; Motomura K; Kondo Y; Miyata T; Takahashi M; Wakabayashi T Oncogene; 2012 May; 31(22):2715-24. PubMed ID: 22020337 [TBL] [Abstract][Full Text] [Related]
13. Endothelial cells induce cancer stem cell features in differentiated glioblastoma cells via bFGF. Fessler E; Borovski T; Medema JP Mol Cancer; 2015 Aug; 14():157. PubMed ID: 26282129 [TBL] [Abstract][Full Text] [Related]
14. Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo. Lamour V; Henry A; Kroonen J; Nokin MJ; von Marschall Z; Fisher LW; Chau TL; Chariot A; Sanson M; Delattre JY; Turtoi A; Peulen O; Rogister B; Castronovo V; Bellahcène A Int J Cancer; 2015 Sep; 137(5):1047-57. PubMed ID: 25620078 [TBL] [Abstract][Full Text] [Related]
15. The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma. Kaur H; Ali SZ; Huey L; Hütt-Cabezas M; Taylor I; Mao XG; Weingart M; Chu Q; Rodriguez FJ; Eberhart CG; Raabe EH Cancer Lett; 2016 Jul; 377(1):55-64. PubMed ID: 27102002 [TBL] [Abstract][Full Text] [Related]
16. Lipid metabolism enzyme ACSVL3 supports glioblastoma stem cell maintenance and tumorigenicity. Sun P; Xia S; Lal B; Shi X; Yang KS; Watkins PA; Laterra J BMC Cancer; 2014 Jun; 14():401. PubMed ID: 24893952 [TBL] [Abstract][Full Text] [Related]
17. Regulation of glioblastoma multiforme stem-like cells by inhibitor of DNA binding proteins and oligodendroglial lineage-associated transcription factors. Wu Y; Richard JP; Wang SD; Rath P; Laterra J; Xia S Cancer Sci; 2012 Jun; 103(6):1028-37. PubMed ID: 22380883 [TBL] [Abstract][Full Text] [Related]
18. Differential role of EGF and BFGF in human GBM-TIC proliferation: relationship to EGFR-tyrosine kinase inhibitor sensibility. Bajetto A; Porcile C; Pattarozzi A; Scotti L; Aceto A; Daga A; Barbieri F; Florio T J Biol Regul Homeost Agents; 2013; 27(1):143-54. PubMed ID: 23489694 [TBL] [Abstract][Full Text] [Related]
19. STON2 negatively modulates stem-like properties in ovarian cancer cells via DNMT1/MUC1 pathway. Xu S; Yue Y; Zhang S; Zhou C; Cheng X; Xie X; Wang X; Lu W J Exp Clin Cancer Res; 2018 Dec; 37(1):305. PubMed ID: 30518424 [TBL] [Abstract][Full Text] [Related]
20. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma. Geng S; Guo Y; Wang Q; Li L; Wang J Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]